Zobrazeno 1 - 5
of 5
pro vyhledávání: '"A. V. Rosinskaya"'
Autor:
Ekaterina I. Semenova, Ivan N. Vlasov, Suzanna A. Partevian, Anna V. Rosinskaya, Ivan N. Rybolovlev, Petr A. Slominsky, Maria I. Shadrina, Anelya Kh. Alieva
Publikováno v:
Cells, Vol 11, Iss 16, p 2599 (2022)
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. Investigating individuals with the most identical genetic background is optimal for minimizing the genetic contribution to gene expression. These individuals include mon
Externí odkaz:
https://doaj.org/article/6bbde47c4a0b41de95b91dc26dc7d5fd
Autor:
Ivan N. Vlasov, Anelya Kh. Alieva, Ekaterina V. Novosadova, Elena L. Arsenyeva, Anna V. Rosinskaya, Suzanna A. Partevian, Igor A. Grivennikov, Maria I. Shadrina
Publikováno v:
Cells, Vol 10, Iss 12, p 3478 (2021)
Parkinson’s Disease (PD) is a widespread severe neurodegenerative disease that is characterized by pronounced deficiency of the dopaminergic system and disruption of the function of other neuromodulator systems. Although heritable genetic factors c
Externí odkaz:
https://doaj.org/article/33881fe906cc4ba3b97805b6b0673fc6
Autor:
Anna V Rosinskaya, M.M. Rudenok, E. L. Arsenyeva, Anelya Kh. Alieva, Ivan N Vlasov, Petr Slominsky, E. V. Novosadova, Igor A. Grivennikov, Maria Shadrina
Publikováno v:
Journal of Molecular Neuroscience
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. In most cases, the development of the disease is sporadic and is not associated with any currently known mutations associated with PD. It is believed that changes associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a3ceb6bed2bc61fa0efd988de383b9
https://doi.org/10.1007/s12031-019-01452-3
https://doi.org/10.1007/s12031-019-01452-3
Publikováno v:
Neuroscience and Behavioral Physiology. 49:937-941
Objectives. To optimize levodopa treatment depending on the rate of disease progression. Materials and methods. A total of 86 patients with Parkinson’s disease were studied. The rate of progression was evaluated in terms of the time taken to reach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ef6d5a7d3ff0509898b1189b1c5965e
https://doi.org/10.1007/s11055-019-00822-z
https://doi.org/10.1007/s11055-019-00822-z
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 118(6. Vyp. 2)
To optimize therapy with levodopa preparations in relation to the rate of disease progression.Eighty-six patients with Parkinson's disease (PD) were studied. Rate of progression was assessed by time of developing the 3rd stage of the disease. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9732cdb00814ab879df12bda03af74b
https://pubmed.ncbi.nlm.nih.gov/30346438
https://pubmed.ncbi.nlm.nih.gov/30346438